Pfizer Inc and BioNTech's new proposal with the European Union includes a provision for member states to pay half price, or about 10 euros ($11), for each of about 70 million cancelled COVID-19 doses, the Financial Times reported on Sunday.
The revised contract would allow the EU to upgrade to newer vaccines tailored to any future COVID-19 variants, the report added, citing people close to negotiations.
https://finance.yahoo.com/news/pfizer-biontech-propose-eu-pays-042630714.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.